SecBot SecBot

ENSCW

Ensysce Biosciences, Inc.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001716947 Biotech & Drug Discovery
Warrants of Ensysce Biosciences, Inc. · ENSC stock page →
$0.4500 −0.02 (−4.46%)
Oct 26 4:00 PM ET · prev $0.4710
Market cap
$9.9M
Nano cap
1 year
−79.0%
from $2.14 · Oct 27
30 days
+12.2%
from $0.4010
52-week range
$0.2510–2.18
−79% from high · low Jun 12
Avg volume 20D
582.4K
Oct 9 spike 2.68M
Short interest
58.6K
0.0%
Days to cover
2.5
at average volume
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 5 reports · latest
Balance 3 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 5/5
Strongest BEARISH Ensysce Biosciences filed an S-3 registration statement to register 1,300,000 shares of common stock for…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • Short sellersSTEADY

    Short interest 0.0% to 58.6K shares. 2.5 days to cover.

  • TrendUPTREND

    1% above its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 4, 2026 SEC
Ensysce Biosciences filed an S-3 registration statement to register 1,300,000 shares of common stock for resale by…
S-3 — Impact 6/10
May 22, 2026 SEC
Ensysce Biosciences received a Nasdaq delisting notice on May 21, 2026 for failing to meet the $2.5M stockholders'…
8-K — Impact 7/10
May 15, 2026 SEC
Ensysce Biosciences reported Q1 2026 results with a net loss of $3.6M, widening from a $1.9M loss in Q1 2025, driven…
8-K — Impact 7/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Next FY———$0.00
Current Q———$1.9M
Next Q———$1.9M
Current FY———$6.8M

Short side

FINRA· Jun 15, 2026
58,552
shares short
0.0%
vs prior settlement
2.5
days to cover

SecBot reports

5 filings · 0 bullish · 3 bearish · 2 neutral
All ENSCW filing & press-release reports (5)